NCT05437471View on ClinicalTrials.gov

Effects of Co-treatment on Endometrial abv3-integrin Expressions in Women With Recurrent Implantation Failure

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

January 1, 2020

Primary Completion Date

December 30, 2021

Study Completion Date

May 30, 2022

Conditions
Miscarriage, Recurrent
Interventions
DRUG

GNRH Analoge, Duphaston, Letrozole

GNRH Analoge, Duphaston, Letrozole

Trial Locations (1)

56000

UniversitiKMMC, Kuala Lumpur

All Listed Sponsors
lead

Universiti Kebangsaan Malaysia Medical Centre

OTHER

NCT05437471 - Effects of Co-treatment on Endometrial abv3-integrin Expressions in Women With Recurrent Implantation Failure | Biotech Hunter | Biotech Hunter